By Philips ∙ Nov 04, 2024 ∙ 3 min read
Healthcare leaders are perpetually in search of ways to enhance efficiency, improve care quality and address inequities in the system. With rising staff shortages contributing to a crisis of access, the integration of AI and automation in healthcare delivery promises a revolution; a seismic shift in how we approach these challenges.
Yet what are the tangible benefits for healthcare institutions, and how can they harness these technologies to catalyze change? Let's delve into findings from the Philips Future Health Index 2024 that point to a future of healthcare augmented by AI and automation.
A patient receives radiology services with Philips equipment.
Staff shortages have become a chronic challenge in healthcare, leading to overworked professionals and compromised patient care. With a staggering 88% of healthcare leaders affirming the importance of technology in easing staff shortages, automation has swiftly moved from a futuristic concept to a tangible solution that's reshaping the administrative landscape.
By automating routine tasks, such as patient check-ins and appointment scheduling, healthcare professionals are free to focus on what they do best: caring for patients. This shift not only enhances productivity but also elevates the quality of care, allowing professionals to operate at their highest skill level.
The impact of automation isn't lost on those at the forefront of healthcare systems. By redirecting the time and energies of their workforce away from mundane tasks, leaders can foster an environment where innovation thrives and patient care is paramount. The numbers speak for themselves: 84% of industry leaders believe that automation will save time on day-to-day tasks, while 76% anticipate it will enable staff to perform at their peak.
With the ability to automate workflow prioritization, equipment maintenance, billing processes, clinical data entry and documentation, healthcare professionals are set up for success and can reach their full potential. For instance, leaders can look to models like the one employed at Nicklaus Children's Health System, where automation of ultrasound measurements and strain quantification in radiology has led to a 51% reduction in quantification time and a 20% decrease in 2D imaging exam time. Such improvements are more than just numbers on a report; they translate into real-world efficiency and better patient outcomes.
AI has made significant advancements in healthcare and is increasingly finding its way into clinical practice. Radiology departments are leading the pack, with 27% of healthcare leaders reporting its implementation for clinical decision support. AI has also made strides with in-hospital patient monitoring (23% reporting implementation) and preventive care (16% reporting implementation).
AI's potential, however, extends far beyond current applications, with leaders reporting plans to increase the adoption of AI within preventive care (36% planning to implement), remote patient monitoring (36% planning to implement) and treatment planning (35% planning to implement) over the next three years. These AI use cases can enhance patient outcomes, improve efficiency and expand access to care beyond hospital walls, charting a course toward a future where AI's insights and efficiencies are integrated into the full patient care continuum.
By leveraging AI's capabilities, healthcare systems can enhance the precision and personalization of patient care, even as they expand their reach to underserved communities. Leaders can anticipate a future where AI-enabled insights not only inform higher quality care but also fortify their institutions against the unpredictability of healthcare demands.
While healthcare leaders are enthusiastic about the benefits of AI and automation, staff remain cautious. There is a notable level of skepticism among industry professionals regarding automation, with 65% of leaders acknowledging this sentiment. Concerns around AI aren't unfounded either. AI, for all its potential, carries the risk of perpetuating biases that could widen disparities in health outcomes. A significant 79% of healthcare leaders share this concern, recognizing the need to ensure that AI applications are ethical and representative of diverse groups.
To navigate these complex waters, healthcare leaders advocate for strategies that include making AI more transparent and interpretable, providing ongoing training and education, improving bias monitoring and detection, enabling diverse and representative data collection, and establishing policies for the ethical use of data and AI. By fostering a culture of continuous learning and ethical vigilance, healthcare systems can mitigate the risks associated with AI, ensuring that its deployment enhances rather than compromises the integrity of patient care.
As AI and automation become embedded within the fabric of healthcare delivery, the education of emerging medical professionals must evolve in tandem. A curriculum that integrates a deep understanding of AI's capabilities, limitations and ethical implications will be paramount in equipping the next generation of healthcare leaders and practitioners. These future professionals need to be as adept with data and technology as they are with patient care, enabling them to navigate the AI-augmented landscape with confidence and competence.
The call to action for healthcare leaders is clear: to prepare their teams for a future where AI and automation are integral to the provision of quality care. By championing the adoption of these technologies, fostering an environment of transparency and education, and nurturing the talents of new medical professionals, we can ensure that the healthcare systems of the future are both technologically advanced and deeply human-centered.
Learn more about the digital transformation happening in healthcare by downloading the Philips Future Health Index 2024.
[1] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. [2] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. [3] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. Japan guidelines [4] Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001. [5] Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61. [6] FDA 510k (#K173860). The iFR modality is intended to be used in conjunction with currently marketed Philips pressure wires. In the coronary anatomy, the iFR modality has a diagnostic cut-point of 0.89 which represents an ischemic threshold and can reliably guide revascularization decisions during diagnostic catheterization procedure. [7] Gotberg M. et al. iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI. Late-breaking clinical Trial presentation at TCT on November 4, 2021.
You are about to visit a Philips global content page
Continue